Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages

scientific article published on 23 September 2014

Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BPH.12747
P932PMC publication ID4280965
P698PubMed publication ID24780080
P5875ResearchGate publication ID261996375

P50authorRenger WitkampQ1960490
Michiel BalversQ59550278
Klaske van NorrenQ88678152
Carolien LuteQ114526650
Jvalini T DwarkasingQ114533670
P2093author name stringJocelijn Meijerink
Pierluigi Plastina
Mieke Poland
P2860cites workToll-like receptor signallingQ24570126
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effectsQ24630455
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa BQ24630721
Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysQ26823256
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsQ27860900
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Q28298445
The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammationQ39597767
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritisQ39738345
Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages.Q39854469
Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2).Q39980249
AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cellsQ40044564
TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathwayQ40078950
Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.Q41093128
Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties.Q42824955
Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cellsQ43818292
15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonistQ43961283
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamideQ44528750
Endocannabinoid signaling in cancer: a rather complex puzzleQ46193469
MADMAX - Management and analysis database for multiple ~omics experiments.Q50188508
Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles.Q53359277
Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil dietQ57116940
Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine RetinaQ60690628
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient miceQ74280029
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamideQ79409358
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsQ29616817
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsQ30486707
The Concise Guide to PHARMACOLOGY 2013/14: ion channelsQ30486735
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptorsQ30486738
The Concise Guide to PHARMACOLOGY 2013/14: enzymes.Q30486745
Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signalsQ30504292
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genusQ31134484
CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsisQ33488512
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cellsQ33581824
Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteinsQ33750716
Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscleQ33785681
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathyQ33847549
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in pigletsQ33946795
Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.Q34014760
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell linesQ34095006
Animal research: reporting in vivo experiments: the ARRIVE guidelinesQ34116755
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseQ34188446
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptorQ34418713
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasmaQ34559890
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoidsQ35643909
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissuesQ36353394
The peripheral cannabinoid receptor knockout mice: an updateQ36416347
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injuryQ36431793
Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?Q36620178
Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiologyQ36893211
The complications of promiscuity: endocannabinoid action and metabolismQ36944706
Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.Q37370591
Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.Q37376934
The cannabinoid receptor 2 is critical for the host response to sepsisQ37390259
The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.Q37568632
n-3 fatty acids in cardiovascular diseaseQ37893165
Return to homeostasis: downregulation of NF-κB responsesQ37902868
Fatty acids and inflammation: the cutting edge between food and pharma.Q37911577
Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent functionQ38041843
Guidelines for reporting experiments involving animals: the ARRIVE guidelinesQ39512979
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
endocannabinoidsQ10483908
P304page(s)24-37
P577publication date2014-09-23
P1433published inBritish Journal of PharmacologyQ919631
P1476titleInhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages
P478volume172

Reverse relations

cites work (P2860)
Q39721348Analysis of Omega-3 Fatty Acid Derived N-Acylethanolamines in Biological Matrices.
Q47948005Anti-inflammatory ω-3 endocannabinoid epoxides.
Q65002446Capsaicin Analogues Derived from n-3 Polyunsaturated Fatty Acids (PUFAs) Reduce Inflammatory Activity of Macrophages and Stimulate Insulin Secretion by β-Cells In Vitro.
Q41521095Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
Q45951325Effects and mechanisms of docosahexaenoic acid on the generation of angiopoietin-2 by rat brain microvascular endothelial cells under an oxygen- and glucose-deprivation environment.
Q91994076Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
Q55497668In Vitro Anti-Inflammatory and Radical Scavenging Properties of Chinotto (Citrus myrtifolia Raf.) Essential Oils.
Q92636751Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
Q98773600N-Docosahexaenoyl ethanolamine (Synaptamide) has antinociceptive effects in male mice
Q90195067N-Eicosapentaenoyl Dopamine, A Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages
Q92912064Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
Q88316705Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage
Q38709659The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line
Q35754749Transcriptome Profiling and Molecular Pathway Analysis of Genes in Association with Salinity Adaptation in Nile Tilapia Oreochromis niloticus
Q90735883n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer

Search more.